石四药集团(02005.HK):集团的维生素A棕榈酸酯已获药监局批准登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shihua Pharmaceutical Group has received approval from the National Medical Products Administration of China for its Vitamin A Palmitate to be used as an active pharmaceutical ingredient in marketed formulations [1] Group 1 - The Vitamin A Palmitate is primarily used in fat-soluble vitamin injections to supplement vitamins [1]

SSY GROUP-石四药集团(02005.HK):集团的维生素A棕榈酸酯已获药监局批准登记成为在上市制剂使用的原料药 - Reportify